This inventor holds 1 USPTO granted patent. Top assignee: Acadia Pharmaceuticals Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Mark Donald Knowles: Innovator in Alzheimer's Disease Treatment
Introduction
Mark Donald Knowles is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medicine, particularly in the treatment of Alzheimer's disease psychosis. His innovative approach has the potential to improve the quality of life for many individuals suffering from this condition.
Latest Patents
Mark Donald Knowles holds a patent for "Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis." This patent outlines methods for treating Alzheimer's disease psychosis, including administering pimavanserin or its pharmaceutically acceptable salts. The patent also details methods for reducing delusions, hallucinations, and agitated or aggressive behavior in individuals with dementia.
Career Highlights
Knowles is associated with Acadia Pharmaceuticals Inc., where he continues to work on innovative solutions for neurological disorders. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Throughout his career, Mark has collaborated with esteemed colleagues such as Bruce Duane Coate and James Randall Owen. These partnerships have fostered a collaborative environment that enhances the development of effective treatments.
Conclusion
Mark Donald Knowles is a pioneering inventor whose work in Alzheimer's disease treatment exemplifies the impact of innovation in healthcare. His contributions are vital in the ongoing fight against neurological disorders, and his patent reflects a commitment to improving patient outcomes.